Who owns SEELOS THERAPEUTICS INC CLASS EQUITY?
- CUSIP Number: 81577f307
Tip: Access positions for across all investors
Analyze quarterly positions in Seelos Therapeutics Inc Class Equity with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Seelos Therapeutics Inc Class Equity stock
Who bought or sold SEELOS THERAPEUTICS INC CLASS EQUITY this quarter?
There are no current stakeholders of Seelos Therapeutics Inc Class Equity.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Seelos Therapeutics Inc Class Equity?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AdvisorShares Investments | Jun 2024 | 90k | $56k |
| Modera Wealth Management | Jun 2024 | 21k | $13k |
| Geode Capital Management | Jun 2024 | 13k | $7.6k |
| Tower Research Capital | Jun 2024 | 3.9k | $2.3k |
| Carmichael Hill & Associates | Jun 2024 | 1.0k | $597.000000 |
| Jpmorgan Chase & Co | Jun 2024 | 501.00 | $501.000000 |
| Bank of America Corporation | Jun 2024 | 472.00 | $282.020000 |
| Group One Trading | Jun 2024 | 216.00 | $128.995200 |
| Vermillion & White Wealth Management Group | Jun 2024 | 123.00 | $73.000500 |